FOI release

VMD FOI requests received 1 July to 31 December 2022

Published 22 September 2023

1. Information and Communications Technology (ICT) arrangements

ATI number Summary
ATI0806 Information on authority’s devices and services contract(s)
ATI0808 Information on authority’s devices and services contract(s)
ATI0814 Information on ICT devices /hardware /expenditure
ATI0822 Information on organisation’s contracts around ICT contract(s)
ATI0832 Details of call centre contracts and contracts
ATI0838 Information on organisation’s contracts around ICT contract(s)

2. Authorisations

ATI number Summary
ATI0805 Information on cannabinoid containing veterinary products which are pending for a marketing authorisation
ATI0811 Information on Dorset’s Scullcap & Valerian tablets that allowed you to licence them for their use in the management of anxiety in cats and dogs
ATI0820 Information on the number of Redwater Fever (Babesiosis) vaccination doses issued over the last 10 years
ATI0823 Information on MRNA injections
ATI0827 Information on SICs issued for Gamaret
ATI0833 Information on which Sheep dips contained Cresylic Creosote in 1991
ATI0834 Information on which Sheep dips contained Cresylic Creosote in 1989
ATI0835 Information on which Sheep dips contained Cresylic Creosote in 1986
ATI0840 Information of history of authorised products

3. Pharmacovigilance

ATI number Summary
ATI0799 Report on the numbers of incidents relating to this drug
ATI0800 Information on adverse drug reactions reported for Simparica Trio
ATI0801 Information on moxidectin, spinosad, afoxolaner, lufenuron and flumethrin sales
ATI0802 Information of sales of fipronil, imidacloprid, fluralaner, selamectin, flumethrin, afoxolaner and spinosad
ATI0803 Usage/sales data relating to parasiticide APIs
ATI0804 Information on imidacloprid and fipronil products
ATI0807 Usage/sales data relating to parasiticide APIs
ATI0810 Usage/sales data relating to parasiticide APIs
ATI0815 Adverse reports on dogs and parasite control
ATI0817 Usage/sales data relating to parasiticide APIs
ATI0821 Usage/sales data relating to parasiticide APIs
ATI0824 Information of other FOI requests
ATI0828 Information on serious adverse events for endectocides
ATI0836 Information on adverse event reactions to canine vaccines, and sales of vaccines
ATI0839 Reports of adverse reactions in dogs since 2018 for a specific product
ATI0841 Reports of adverse reactions to authorised canine vaccines

4. Residues

ATI number Summary
ATI0837 Information on antibiotics and chemicals

5. Legislation

ATI number Summary
ATI0829 Information on which sheep dips contained Cresylic Creosote in 1990
ATI0830 Information on Cresylic Creosote used in some scab-approved sheep dips, in 1990

6. Business Support

ATI number Summary
ATI0809 Information on grants
ATI0812 Information on organisation, contract’s register
ATI0813 Information on courier services
ATI0816 Information on the number of staff who are contractual home workers
ATI0818 Expenditure on equality, diversity, and inclusivity
ATI0819 Expenditure on equality, diversity, and inclusivity
ATI0825 Information on contracts and suppliers
ATI0826 Information on contracts and suppliers
ATI0831 Information on the 1990 membership of the Veterinary Products Committee
ATI0842 Information on the number of staff working at the organisation